###begin article-title 0
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
A novel COL1A1 nonsense mutation causing osteogenesis imperfecta in a Chinese family
###end article-title 0
###begin p 1
The first two authors contributed equally to this publication.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
To identify the genetic defect of osteogenesis imperfecta (OI) type I in a large Chinese family of five generations.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
Seventeen members in an OI type I family were recruited, and clinical examinations were performed. All members were genotyped with microsatellite markers at loci associated with OI. A two-point LOD score was calculated using the Linkage package. A mutation was detected by direct sequencing.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 299 305 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
All affected individuals in the family had fractured a bone more than once, and their sclerae were blue. Significant evidence of linkage was obtained at markers D17S1180 (LOD score [Z]=2.91, at recombination fraction [theta]=0.0) and D17S1319 (Z=2.20, at theta=0.0), respectively. Sequencing of the COL1A1 gene revealed a C>T transition in exon 36, which caused a substitution of Gln at codon 644 to a stop codon (Q644X). This mutation was not observed in unaffected or 100 normal unrelated individuals.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
This study is the first report that OI is associated with the mutation Q644X of COL1A1.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 696 697 696 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
Osteogenesis imperfecta (OI) is an autosomal-dominant connective tissue disorder characterized by brittle bones together with associated features such as short stature, dentinogenesis imperfecta, hyperlaxity of ligaments and skin, blue sclera, and hearing loss [1]. The ocular manifestations of OI are not usually sight threatening and typically consist of blue sclerae. Other ocular manifestations that may occur include perinuclear or cortical cataract, megalocornea, microcornea, keratoconus, nystagmus, glaucoma, ptosis, etc. The minimum prevalence of OI is estimated to be 1/10,000-1/30,000 [1,2]. Traditionally, it is usually classified into four types depending on phenotype and severity [3,4]. Type I is the most common and mildest deforming. Type II is the most severe and is lethal in the perinatal period. Type III is severely deforming, and fractures are often present at birth. Type IV is moderately deforming; its severity is between Type I and Type III.
###end p 12
###begin p 13
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
###xml 495 496 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
More than 250 mutations in one of the two genes, COL1A1 and COL1A2, which encode the proalpha1 and proalpha2 chains of collagen I, respectively, have been found in unrelated probands with the disease. Most of these mutations are single nucleotide changes, mostly resulting in a substitution for a glycine residue and disrupting the continuous Gly-X-Y sequence of the collagen triple helix. Others are in-frame, single exon splicing defects, and a few are deletions, duplications, or insertions [1].
###end p 13
###begin p 14
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
To identify the genetic defect of OI type I in a large Chinese family of five generations, we carried out linkage analysis and identified a COL1A1 nonsense mutation in a Chinese OI type I family. In exon 36 of COL1A1 gene, a C to T transition at position 2,464 resulted in a glutamine (Gln) to stop codon substitution at codon 644 (Q644X). This mutation (Q644X) appeared to be novel, which is neither reported in the literature nor registered in the . We also found that the central corneal thickness (CCT) of the OI patients were much lower than normal.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
DNA specimens
###end title 16
###begin p 17
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
The protocol for the study was approved by the Ethics Committee of our institute. Informed consent was obtained from all family members participating in this study. The family comprised 22 affected individuals from a five generation pedigree, originating from the Hebei province, China. The study consisted of 17 members, including 8 affected individuals, 6 unaffected individuals, and 3 normal controls (Figure 1).
###end p 17
###begin p 18
The osteogenesis imperfecta pedigree and haplotype analysis. Pedigree and haplotype analysis of the OI family showing segregation of four microsatellite markers on chromosome 17. Squares symbolize males, and circles represent females. Black and white lines denote affected and unaffected status, respectively.
###end p 18
###begin title 19
Clinical evaluations
###end title 19
###begin p 20
The past history was investigated and the systems review was performed. The detailed ocular examinations of the proband were performed and some parameters were measured including vision, IOP, CCT, ocular axis length, and corneal curvature.
###end p 20
###begin title 21
Genotyping
###end title 21
###begin p 22
Exclusion analysis was performed by allele sharing of the microsatellite markers, which were linked with the known OI loci. Genotyping was performed using microsatellite markers D17S1293, D17S1180, D17S1319, and D17S788 at 17q 11.2-22. The oligonucleotide primer sequences were taken from  and .
###end p 22
###begin title 23
Linkage analysis
###end title 23
###begin p 24
A two-point LOD score (Z) was calculated using the MLINK subprogram of the Linkage package (version 5.1). The mode of inheritance was considered to be autosomal dominant with 95% penetrance. The gene frequency was set at 1/15,000. As the allelic frequencies of the polymorphic markers are unknown in the Chinese population, they were considered to be equally distributed.
###end p 24
###begin title 25
DNA sequencing
###end title 25
###begin p 26
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
COL1A1 () was screened for mutations by direct sequencing. PCR products of the 51 exons and flanking intron sequences of COL1A1 were sequenced on an ABI-3730 DNA Analyzer (Applied Biosystems, Foster City, CA). Oligonucleotide primers and conditions for amplification are available upon request.
###end p 26
###begin title 27
Denaturing HPLC
###end title 27
###begin p 28
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
To screen for the mutation identified in the patients, on remaining patients, family members, and 100 normal control subjects in exon 36 of the COL1A1 gene, Denaturing (D)HPLC was involved by using a commercial system (Wave DHPLC; Transgenomic, San Jose, CA). The sequence for DHPLC was: 5'-CCT CCA TTA CTG CTC CTC CCC-3' for the forward primer, and 5'-GAG GGC CAA GCC ACT CAC AA-3' for the reverse primer. The touchdown PCR profile was used, 95 degreesC during 5 min, then 10 cycles of denaturation at 95 degreesC (30 s), primer annealing at 63 degreesC (30 s) with the temperature decreasing 0.8 degreesC at each cycle, polymerization for 30 s at 72 degreesC; followed by 35 cycles with the same profile for denaturation and polymerization but with a constant annealing temperature of 55 degreesC. Polymerization was completed by an incubation of 10 min at 72 degreesC. DHPLC was performed as follows: initial concentration at 51% of buffer A (0.1 M triethylammonium acetate-TEAA; Transgenomic), and 49% of buffer B (0.1 M TEAA containing 25% acetonitrile; Transgenomic) at 64.7 degreesC.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Clinical data
###end title 30
###begin p 31
###xml 207 215 207 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 184 187 <span type="species:ncbi:9606">boy</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
All affected individuals in the family had fractured their long bones several times from minor trauma and their sclerae have been blue since birth. The proband (V:3) was a 14-year-old boy with blue sclerae (Figure 2). His uncorrected visual acuity was OD, 20/10; OS, 20/10. His intraocular pressures (Goldmann tonometry) were OD, 14.7 mmHg; OS, 18.3 mmHg. His corneal curvature measurements were OD, K1 43.3, K2 43.6; OS, K1 43.0, K2 44.0. The ocular axis lengths were normal: OD, 24.03 mm; OS, 24.23 mm. His CCT were low: OD, 434 mm; OS, 441 mm. No systemic or other ocular anomalies were observed in the patients.
###end p 31
###begin p 32
###xml 77 80 <span type="species:ncbi:9606">boy</span>
The blue sclera of affected individuals. The proband (V:3) was a 14-year-old boy, whose sclerae were blue. The thinning of the sclera makes it possible to transmit the light reflected from the underlying uveal pigment and gives it the bluish color observed clinically. His uncorrected visual acuity was OD, 20/10; OS, 20/10. His intraoclar pressures (Goldmann tonometry) were OD, 14.7 mmHg; OS, 18.3 mmHg. His keratometry evaluation revealed the following: OD, K1 43.3, K2 43.6; OS, K1 43.0, K2 44.0. The ocular axis lengths were normal: OD, 24.03 mm; OS, 24.23 mm. His CCT were low: OD, 434 mm; OS, 441 mm. The other ocular examinations including the anterior chamber and the fundus had no positive findings.
###end p 32
###begin title 33
Linkage and haplotype analysis
###end title 33
###begin p 34
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
###xml 288 296 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 492 499 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
Allele-sharing analysis confirmed the linkage of the disease in the family with COL1A1 and no linkage with COL1A2 (data not shown). Haplotype analysis showed that all the affected individuals shared a common haplotype with markers D17S1293, D17S1180, D17S1319, and D17S788 at 17q11.2-22 (Figure 1). Significant evidence of linkage was observed with microsatellite markers D17S1180 (LOD score [Z]=2.91, at recombination fraction [theta]=0.0) and D17S1319 (Z=2.20, at theta=0.0), respectively (Table 1).
###end p 34
###begin title 35
Two-point LOD scores for linkage between the OI locus and 17q11.2-22 markers.
###end title 35
###begin p 36
Two-point LOD scores of 2.91 at theta=0.0 with marker D17S1180, 2.20 at theta=0.0 with marker D17S1319, and 2.04 at theta=0.0 with marker D17S1293 were obtained.
###end p 36
###begin title 37
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
Mutation detection of COL1A1
###end title 37
###begin p 38
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 136 144 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
Direct cycle sequencing of the amplified fragments of COL1A1 in two affected individuals identified a single base alteration of C2464T (Figure 3) in exon 36 of COL1A1, which resulted in a substitution of Gln at codon 644 to a stop codon (Q644X). Denaturing HPLC analysis confirmed this mutation, which cosegregated with all affected individuals in the family, and was not observed in any of the unaffected family members or 100 normal controls. The remainder of the coding sequence did not show any change.
###end p 38
###begin p 39
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
DNA sequence chromatograms of the unaffected and affected members in the family. A single transition was observed at position 2464 (C>T) of COL1A1, causing a substitution of Gln to a stop codon at codon 644 (Q644X). This resulted in a truncated protein.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
OI is an autosomal-dominant disorder of connective tissue associated with defects in the structure or synthesis of type I collagen [5,6]. OI is clinically characterized by increased bone fragility with a propensity to fracture, often resulting in skeletal deformity. Typical manifestations also include hearing loss, dental abnormalities, and blue sclerae.
###end p 41
###begin p 42
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 62 69 <span type="species:ncbi:9606">patient</span>
###xml 797 804 <span type="species:ncbi:9606">patient</span>
Although the spectrum of clinical features is wide, and an OI patient with Rieger's anomaly has been reported [7], the typical ocular finding is blue sclera. The sclerae of OI can vary in color from normal to a slightly bluish or slate color to a bright blue [8]. The blue sclerae may result from thinning of the abnormal sclera [9], the uniformity of the scleral collagen fibers, the reduced number of collagen bundles, and the increased mucoid components within the sclera [10]. All of these alterations in the ultrastructure of the sclera may, in essence, allow it to behave more like corneal tissue, transmitting the light reflected from the underlying uveal pigment and giving it the bluish color observed clinically. Histopathologic and electron-microscopic examination of an eye from an OI patient revealed that the sclera was moderately thinned especially at the equator; the Bowman's layer in the cornea was absent; and the collagen fibers of the cornea and the sclera were narrower than in the control [10].
###end p 42
###begin p 43
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
As observed in our study, the CCT of OI patients is often low while the vision is usually not affected. Moreover, both CCT and ocular rigidity are negatively correlated with the presence of blue sclerae [11]. Therefore, for such patients, an ophthalmologist must be aware of an artificially low intraocular pressure (IOP) measurement resulting from the low CCT and the decreased ocular rigidity. Furthermore, when considering a keratorefractive treatment, the clinician should evaluate carefully the CCT to avoid unexpected results or complications [11]. In our study, the IOP of the left eye of the proband was 18.3 mmHg, and it may be harmful to such a low CCT. It was suggested to the proband that he come back to the hospital for eye examinations every six months.
###end p 43
###begin p 44
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
###xml 443 450 <span type="species:ncbi:9606">patient</span>
The cornea and the sclerae are known to be thinner in OI patients due to the defective collagen synthesis. The eyeball may distend because of the IOP. We expected longer ocular anteroposterior diameter in such patients, and we measured this parameter. However, the ocular axis lengths of our 14-year-old proband were within the normal range. We speculate that the ocular axis length of OI patients may be in correlation with their age. As the patient ages, the "cumulative effect" of the persistent intraocular pressure on the relatively thin and weak eyeball may lengthen the ocular axis.
###end p 44
###begin p 45
###xml 35 48 35 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1/COL1A2</italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
Since 1980s, when the mutations in COL1A1/COL1A2 were first described, over 250 mutations in these two genes have been found in OI patients with various phenotype from diverse racial and ethnic groups ( and the ). The vast majority are missense point mutations that convert codons for the obligate glycines in the triple helix of type I collagen to codons for amino acids with bulkier side chains [12-14]. The helical domain of type I collagen is composed of uninterrupted repeats of the sequence Gly-X-Y, in which Gly is glycine, and X and Y could be any residue but cysteine or tryptophan. The presence of glycine at every third residue is crucial to helix formation because its small side chain can be accommodated in the spatial constraints of the interior of the helical trimer [15]. Therefore, the substitution of a glycine residue by an amino acid with a bulky, polar, or charged side chain will distort the conformation of the triple helix and perturb normal collagen assembly in the cell, secretion from the cell, or fibril assembly in the extracellular spaces, and finally, often lead to a severe OI phenotype (type II) [13,16].
###end p 45
###begin p 46
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 695 696 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 340 346 <span type="species:ncbi:9606">person</span>
Although several, apparently more common, mutations have been reported in more than one unrelated individual or family with a similar OI phenotype [12,14,15,17,18], the relationships between the phenotype and genotype are not clear yet. In the vast majority of cases, the mutations are "private" in that they have only been reported in one person or family [19]. In spite of this, we can still obtain some rough correlation between the phenotype and genotype, such as the more NH2-terminal a serine substitution is located, the more severe the phenotype tends to be [20]. Glycine substitutions at the COOH-terminal half of the protein result in a more severe phenotype, while mutations at the NH2-terminal half tend to manifest in a less severe phenotype [21]. The missense point mutation occurring at glycine codon tends to result in a lethal phenotype, while the mutation creating a premature stop codon often leads to a mild, type I phenotype [13] etc. In conclusion, the severity of the phenotype is strongly associated with the specific site of the mutation.
###end p 46
###begin p 47
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 473 479 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
The mutation analysis of OI is a labor intensive, expensive process due to the "private" nature of offending mutations and their nonclustered distribution in considerably sized genes [22]. Therefore, in our study, members of the family were genotyped first with microsatellite markers at the two known loci of OI. Haplotype analysis showed that the affected individuals in this family shared a common haplotype with four markers, within the region of 17q11.2-22, where the COL1A1 gene is located. After screening COL1A1 for mutations by direct sequencing, we identified a C>T transition in exon 36 of the gene. The transition C2464T located in exon 36 was predicted to cause a substitution of Gln to a stop codon at codon 644 (Q644X). DHPLC was used as a rapid, inexpensive method to confirm the mutation. The results showed that this mutation cosegregated with all affected individuals and was not observed in unaffected family members or 100 normal unrelated individuals.
###end p 47
###begin p 48
###xml 138 144 134 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 419 421 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 432 438 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 525 527 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 668 670 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 938 940 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1203 1205 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1206 1208 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1209 1211 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 1212 1214 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1365 1371 1357 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
The nonsense mutation in our study, Q644X, could cause one alpha1(I) allele to be functionally void. The transcription products of such a COL1A1 gene are usually unstable and subjected to degradation via nonsense-mediated mRNA decay pathways (NMD), ultimately producing a truncated protein. The NMD is a universal phenomenon and describes the degradation of mRNA transcripts that contain premature termination signals [23]. For the COL1A1 gene, NMD is a nuclear phenomenon. It targets mRNA rather than hnRNA for degradation [24]. The recognition and decay of nonsense containing COL1A1 mRNA occurs either during or after splicing but prior to cytoplasmic translation [24]. Regardless of the position of the mutation within the gene or its relative position within an exon, the steady-state amounts of mRNA from the mutant allele can be reduced markedly by NMD in both cellular and nuclear RNA extracts of cells from affected individuals [23]. Bioinformatic analyses also showed that Q644 is located in a highly conserved region (data not shown). As a result, a reduced amount of structurally normal collagen type I chains are expressed by fibroblasts of affected individuals, thus leading to OI type I [13-15,19,25]. This study confirms that the decreased expression of proalpha1(I) chains resulting from premature-termination codons or RNA-splicing defects in the COL1A1 gene often leads to the mildest OI.
###end p 48
###begin p 49
###xml 86 92 86 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 773 779 773 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
To our knowledge, 13 nonsense mutations have been described at the collagen domain of COL1A1: R42X [13], R75X [22], R183X [13,14,22], R237X [18,22], R294X [26], R420X [27], E500X [14], R519X [13], R704X [28], Q779X [22], R848X [22,28], R963X [12,29], and Q644X (in our study). Two have been found at the COOH-terminal domain: W1269X [26], W1325X [28]. All of the aforenamed nonsense mutations predictably led to OI type I except W1269X, which resulted in OI type IV. The majority of these converted CGA, which encodes arginine to TGA and creates a premature stop codon. Our study is the second reported nonsense mutation converting a glutamine codon to a premature stop codon. These results suggest that close attention should be paid to arginine codons when screening the COL1A1 for mutations.
###end p 49
###begin p 50
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 497 503 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 100 105 <span type="species:ncbi:9606">Human</span>
Until our report, there were seven point mutations in exon 36 of COL1A1 that were registered in the Human Type I and Type III Collagen Mutation Database. All of these mutations were missense mutations that converted a glycine codon to a serine, asparagine, or an arginine codon. Most of these mutations resulted in the severe OI type II. The Q644X in our study is the first nonsense mutation observed to occur in exon 36, and it also indicates that the coding sequence in exon 36 is essential for COL1A1's function.
###end p 50
###begin title 51
Acknowledgements
###end title 51
###begin p 52
The authors thank the family for participation in this project. We also thank Dr. Hua Liu, Dr. Wenjiang Ma, and Dr. Dan Hu for sample collection, Dr. Chen Qi for clinical examination, and Dr. Xiaolin Hao and Miss Meng Zhang for excellent technical assistance. This work is partly supported by the National "973" Basic Research Funding Scheme of China (grant number 2001CB5103) and National Infrastructure Program of Chinese Genetic Resources (2004DKA30490).
###end p 52
###begin title 53
References
###end title 53
###begin article-title 54
###xml 16 24 <span type="species:ncbi:9606">children</span>
Hearing loss in children with osteogenesis imperfecta.
###end article-title 54
###begin article-title 55
Genetic heterogeneity in osteogenesis imperfecta.
###end article-title 55
###begin article-title 56
Osteogenesis imperfecta: an expanding panorama of variants.
###end article-title 56
###begin article-title 57
The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta.
###end article-title 57
###begin article-title 58
Phenotype variability in a daughter and father with mild osteogenesis imperfecta correlated with collagen and prolidase levels in cultured skin fibroblasts.
###end article-title 58
###begin article-title 59
Rieger's anomaly and other ocular abnormalities in association with osteogenesis imperfecta and a COL1A1 mutation.
###end article-title 59
###begin article-title 60
Management of retinal detachment in osteogenesis imperfecta.
###end article-title 60
###begin article-title 61
Correlation of ocular rigidity and blue sclerae in osteogenesis imperfecta.
###end article-title 61
###begin article-title 62
Histopathologic and electron-microscopic features of corneal and scleral collagen fibers in osteogenesis imperfecta type III.
###end article-title 62
###begin article-title 63
Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera.
###end article-title 63
###begin article-title 64
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Two new recurrent nucleotide mutations in the COL1A1 gene in four patients with osteogenesis imperfecta: about one-fifth are recurrent.
###end article-title 64
###begin article-title 65
###xml 159 167 <span type="species:ncbi:9606">patients</span>
Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations.
###end article-title 65
###begin article-title 66
###xml 39 47 <span type="species:ncbi:9606">patients</span>
COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta.
###end article-title 66
###begin article-title 67
Clinical and genetical aspects of autosomal dominantly inherited osteogenesis imperfecta tarda.
###end article-title 67
###begin article-title 68
A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
###end article-title 68
###begin article-title 69
Substitution of glycine-661 by serine in the alpha1(I) and alpha2(I) chains of type I collagen results in different clinical and biochemical phenotypes.
###end article-title 69
###begin article-title 70
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Molecular findings in Brazilian patients with osteogenesis imperfecta.
###end article-title 70
###begin article-title 71
###xml 82 89 <span type="species:ncbi:9606">patient</span>
Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.
###end article-title 71
###begin article-title 72
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Serine for glycine substitutions in the C-terminal third of the alpha 1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta.
###end article-title 72
###begin article-title 73
###xml 47 54 <span type="species:ncbi:9606">patient</span>
A missense mutation in ColA1 in Jewish Israeli patient with mild osteogenesis imperfecta, detected by DGGE.
###end article-title 73
###begin article-title 74
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
###end article-title 74
###begin article-title 75
Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains.
###end article-title 75
###begin article-title 76
Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains.
###end article-title 76
###begin article-title 77
Osteogenesis imperfecta.
###end article-title 77
###begin article-title 78
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV.
###end article-title 78
###begin article-title 79
Osteogenesis imperfecta Type 1: a case presentation with a new mutation in gene COL1A1.
###end article-title 79
###begin article-title 80
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
###end article-title 80
###begin article-title 81
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen.
###end article-title 81

